| 1. |
From the Editor |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 2-2
&NA;,
Preview
|
PDF (1103KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 2. |
Benefits with nicotine in cognitive disorders - not just a pipe dream |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 3-4
Sean Henahan,
Preview
|
PDF (2117KB)
|
|
摘要:
Researchers are clearing the smokescreen surrounding nicotine use in neuropsychiatric disorders. Recent findings indicate that nicotine may have beneficial effects in controlling the symptoms of Tourette's syndrome and may improve cognitive function in Alzheimer's disease. However, researchers remain unconvinced about the feasibility of using nicotine in treating schizophrenia. These findings, and the potential for using nicotinic agonists in cognitive disorders, were discussed at the inaugural conference of the Society for Research on Nicotine and Tobacco [San Diego, US; March 1995].
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 3. |
Managing catamenial epilepsy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 4-4
&NA;,
Preview
|
PDF (1093KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 4. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 5-5
&NA;,
Preview
|
PDF (970KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 5. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 6-6
&NA;,
Preview
|
PDF (1113KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 6. |
Recombinant PAF acetylhydrolase could have broad therapeutic uses |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 7-7
&NA;,
Preview
|
PDF (972KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 8-8
&NA;,
Preview
|
PDF (972KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 8. |
Candoxatril leads the way as new treatment for mild CHF |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 9-10
Sandra MacPherson,
Preview
|
PDF (2289KB)
|
|
摘要:
Candoxatril increased exercise tolerance and reduced symptoms in a study involving 59 patients with mild congestive heart failure (CHF). This is thought to be the first study to demonstrate the effects of a neutral endopeptidase inhibitor on CHF symptoms. The results, which were presented at Heart Failure '95 [Amsterdam, The Netherlands; April 1995], led researchers to say that candoxatril could be used as first-line therapy in mild CHF, or as adjunctive therapy in more severe cases of disease.
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 11-11
&NA;,
Preview
|
PDF (972KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
| 10. |
Focus on protease inhibitors |
| |
Inpharma Weekly,
Volume &NA;,
Issue 984,
1995,
Page 12-12
&NA;,
Preview
|
PDF (983KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1995
数据来源: ADIS
|
首页
